Concepedia

Reverse-phase Protein Microarrays

Reverse-Phase Protein Microarrays is a type of protein microarray in which complex biological samples containing intact proteins are immobilized on a solid support and subsequently probed with specific detection antibodies to enable high-throughput quantitative analysis of protein expression and post-translational modifications across multiple samples.

346

Publications

24.1K

Citations

3.3K

Authors

696

Institutions

Publications per year

2017–2026

120

Variants

Reverse Phase Protein ArraysRppa

Parents

Publications

346

Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer

Katherine A. Hoadley, Christina Yau, Toshinori Hinoue et al. · Cell · 2018 · 2.7K citations · Full text

, , +17

An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer

Katherine Stemke‐Hale, Ana M. González-Angulo, Aňa Lluch et al. · Cancer Research · 2008 · 1K citations · Full text

, , +17

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

Cloud P. Paweletz, Lu Charboneau, Verena E. Bichsel et al. · Oncogene · 2001 · 956 citations

, , +17

Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells

Raoul Tibes, Yihua Qiu, Yiling Lu et al. · Molecular Cancer Therapeutics · 2006 · 758 citations

, , +17

Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer

Todd W. Miller, Bryan T. Hennessy, Ana M. González-Angulo et al. · Journal of Clinical Investigation · 2010 · 545 citations

, , +17

1–5 of 346

Authors

3.3K

  1. GB
    Gordon B. Mills

    The University of Texas MD Anderson Cancer Center, United States

    42 publications · 7.9K citations

    29

    h-index

  2. LA
    Lance A. Liotta

    National Cancer Institute, United States

    44 publications · 3.7K citations

    28

    h-index

  3. YL
    Yiling Lu

    The University of Texas MD Anderson Cancer Center, United States

    27 publications · 5.2K citations

    23

    h-index

  4. EF
    Emanuel F. Petricoin

    George Mason University, United States

    32 publications · 2.7K citations

    23

    h-index

  5. JW
    Julia Wulfkuhle

    George Mason University, United States

    23 publications · 1.4K citations

    19

    h-index

1–5 of 3.3K

Institutions

696

  1. The University of Texas MD Anderson Cancer Center

    Houston, United States

    48 h-index

    923 publications

    92.1K citations

  2. George Mason University

    Fairfax, United States

    25 h-index

    236 publications

    7.3K citations

  3. National Cancer Institute

    Bethesda, United States

    19 h-index

    112 publications

    16.8K citations

  4. National Institutes of Health

    Bethesda, United States

    13 h-index

    78 publications

    13.6K citations

  5. Baylor College of Medicine

    Houston, United States

    12 h-index

    92 publications

    3.3K citations

  6. Center for Cancer Research

    Bethesda, United States

    12 h-index

    36 publications

    2.2K citations

  7. Institut Curie

    Paris, France

    12 h-index

    139 publications

    10.7K citations

  8. Harvard University

    Cambridge, United States

    12 h-index

    70 publications

    60.2K citations

1–8 of 696

Venues

  1. Clinical Cancer Research

    24 publications · 1.9K citations

    22

    h-index

  2. PLoS ONE

    20 publications · 900 citations

    17

    h-index

  3. PROTEOMICS

    11 publications · 834 citations

    11

    h-index

  4. Journal of Proteome Research

    JPR · 10 publications · 453 citations

    10

    h-index

  5. Cancer Research

    9 publications · 1.8K citations

    9

    h-index

1–5